Evidence map›Paper›PMID 29772761›Full record

ArticlePharmaceuticals (Basel, Switzerland)2018

High Concentrations of Sodium Chloride Improve Microbicidal Activity of Ibuprofen against Common Cystic Fibrosis Pathogens.

Adrián J Muñoz, Roxana V Alasino, Ariel G Garro, Valeria Heredia, Néstor H García, David C Cremonezzi, Dante M Beltramo

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04382768 (Extended Compassionate Use Program), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04382768 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Extended Compassionate Use Program (UCA) With Inhalational Ibuprofen in Patients With Acute Respiratory Pathology, Mediated by COVID-19.

TypeinterventionalSponsorQuímica Luar SRLRan2020 to 2021Enrolled40ConditionsCoronavirus Infection, Respiratory Disease, SARS (Disease)ArmsInhaled Hypertonic ibuprofen
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. AnJournal of biomolecular structure & dynamics · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Adrián J MuñozCentro de Excelencia en Productos y Procesos de Córdoba, Gobierno de la Provincia de Córdoba, Pabellón CEPROCOR, Santa María de Punilla, Córdoba CP 5164, Argentina. adrianmunoz30@yahoo.com.ar.
Roxana V AlasinoCentro de Excelencia en Productos y Procesos de Córdoba, Gobierno de la Provincia de Córdoba, Pabellón CEPROCOR, Santa María de Punilla, Córdoba CP 5164, Argentina. v.alasino@gmail.com.
Ariel G GarroCentro de Excelencia en Productos y Procesos de Córdoba, Gobierno de la Provincia de Córdoba, Pabellón CEPROCOR, Santa María de Punilla, Córdoba CP 5164, Argentina. garroariel@hotmail.com.
Valeria HerediaCentro de Excelencia en Productos y Procesos de Córdoba, Gobierno de la Provincia de Córdoba, Pabellón CEPROCOR, Santa María de Punilla, Córdoba CP 5164, Argentina. valeriaheredia90@hotmail.com.
Néstor H GarcíaConsejo Nacional de Investigaciones Científicas y Técnicas, CONICET, Godoy Cruz 2290, C1425FQB CABA, Argentina. nestorhgarcia11@gmail.com.ORCID 0000-0002-9057-9030
David C CremonezziDepartamento de Salud y Educación Cátedra de Patología, Universidad Nacional de La Rioja, La Rioja C 5300, Argentina. dccj35@yahoo.com.ar.
Dante M BeltramoCentro de Excelencia en Productos y Procesos de Córdoba, Gobierno de la Provincia de Córdoba, Pabellón CEPROCOR, Santa María de Punilla, Córdoba CP 5164, Argentina. dbeltramo@ceprocor.uncor.edu.
Centro de Excelencia en Procesos y Productos de Córdoba · ARConsejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidad Católica de Córdoba · ARUniversidad Nacional de Córdoba · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ibuprofen (IBU-H), a widely used anti-inflammatory, also shows a marked antimicrobial effect against several bacterial species, including those involved in cystic fibrosis such as

Indexed as

bactericide activitycystic fibrosisibuprofenP. aeruginosasynergy

Identifiers

PMID29772761
PMCPMC6026927
OpenAlexW2804271522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.